Trygve Holmøy

18PUBLICATIONS
37CO-AUTHORS
Regenerative medicine (incl. stem cells)Social epidemiologyDisease surveillanceMedical virologyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 04, 2026
Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

|Sep 30, 2025
Duration of Current Statin Use and Amyotrophic Lateral Sclerosis Risk: A Norwegian Population-Based Cohort Study.

Ola Nakken, Anders Myhre Vaage, Hein Stigum

|Mar 04, 2025
Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population-Based Cohort Study.

Anders Myhre Vaage, Trygve Holmøy, Jesper Dahl

|Dec 03, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.

Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger

|Jan 08, 2024
A Novel SPAST Variant Associated with Isolated Spastic Paraplegia.

Helle Høyer, Ola Nakken, Trygve Holmøy

|Dec 20, 2023
Premorbid lipid levels and long-term risk of ALS-a population-based cohort study.

Anders Myhre Vaage, Jūratė Šaltytė Benth, Haakon E Meyer

Pageof 3

Frequent Collaborators

7 joint publications

Ola Nakken

3 joint publications

Anders Myhre Vaage

3 joint publications

Haakon E Meyer

1 joint publications

Ole-Bjørn Tysnes